6533b7dcfe1ef96bd12726a2
RESEARCH PRODUCT
Treatment of multiple sclerosis patients after 24 Natalizumab doses: a prospective observational study: the TY-STOP
Marinella ClericoI SchiavettiStefania Federica De MercantiF PiazzaDario GnedV Brescia MorraRaffaella LanzilloA GhezziA BianchiG SalemiS RealmutoP SolaF VitettaPaola CavallaG SupertiD FerraroD PaolicelliM TrojanoMp SormaniLuca Durellisubject
Multiple Sclerosis Natalizumab Ty-STOPSettore MED/26 - Neurologiayear | journal | country | edition | language |
---|---|---|---|---|
2014-01-01 |